Stratification and degree of control of cardiovascular risk factors in hypertensive Spanish population. Results of the DICOPRESS study;Estratificación y grado de control del riesgo cardiovascular en la población hipertensa española. Resultados del estudio DICOPRESS

Medicina Clinica

Volumn 129, Issue 7, 2007, Pages 247-251

  Martín Baranera, Montserrat ^a,g   Campo, Carlos ^b   Coca, Antonio ^c   De La Figuera, Mariano ^d   Marín, Rafael ^e   Ruilope, Luis Miguel ^f  

^a Unidad de Epidemiologia Clinica   (Spain)

^b Departamento médico   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d CAP La Mina   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g Unidad de Epidemiología Clínica   (Spain)

Author keywords

Cardiovascular risk factors; Epidemiology; Hypertension; Spain

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOLOGY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE CONTROL; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; RISK; SMOKING; SPAIN; STRATIFICATION;

EID: 34548550818     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13108347     Document Type: Article

References (28)

1. Pardell H, Tresserras R, Armario P, Hernandez del Rey R. Pharmacoeconomic considerations in the management of hypertension. Drugs. 2000;59 Suppl 2:13-20.
2. World Health Organization. World Health Report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
3. Kannel WB, Wolf J. Sistolic blood pressure, arterial rigidity and risk of stroke. The Framingham study. JAMA. 1981;245:1225-9.
4. Kannel WB, Gordon T. Hypertension as an ingredient of a cardiovascular profile. The Framingham study. Am J Cardiol 1971;27:335-46.
5. Segura J, Campo C, Roldán C, Vigil L, Guerrero L, Rodicio JL, et al. Prevalencia del síndrome metabólico en pacientes con hipertensión arterial: características generales. Hipertensión. 2003;20 Supl 1:1-29.
6. Segura Fragoso A, Rius Mery G. Factores de riesgo cardiovascular en una población rural de Castilla-La Mancha. Rev Esp Cardiol. 1999;52: 577-88.
7. Masia R, Pena A, Marrugat J, Sala J, Vila J, Pavesi M, et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health. 1998;52:707-15.
8. Banegas JR, Rodríguez-Artalejo F, De la Cruz Troca JJ, Guallar-Castillón P, Del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998;32:998-1002.
9. Banegas JR, Rodríguez-Artalejo F, Ruilope LM, Graciani A, Luque M, De la Cruz-Troca JJ, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens. 2002;20:2157-64.
10. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53.
11. The Seventh Report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
12. Bertomeu V. Guías sobre el tratamiento de la hipertensión arterial 2003: ¿aclaran o confunden? Rev Esp Cardiol. 2003;56:940-3.
13. Coca A, Redón J. Guías para el diagnóstico, la evaluación y el tratamiento de la hipertensión arterial: el punto de vista de la Sociedad Española de Hipertensión. Med Clin (Barc). 2003;121: 739-40.
14. Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Guía Española de Hipertensión Arterial. Hipertensión. 2005;22 Supl 2:1-84.
15. Coca A. Evolución del control de la hipertensión arterial en Atención Primaria en España. Resultados del estudio Controlpres 2003. Hipertensión. 2005;22:5-14.
16. Llisterri Caro JL, Rodríguez Roca GC, Alonso Moreno FJ, Lou Arnal S, Divison Garrote JA, Santos Rodríguez JA, et al. Control de la presión arterial en la población hipertensa española atendida en atención primaria. Estudio PRESCAP 2002. Med Clin (Barc) 2004;122:165-71.
17. Rodríguez Roca GC, Artigao Rodenas LM, Llisterri Caro JL, Alonso Moreno FJ, Banegas Banegas JR, Lou Arnal S, et al. Control of hypertension in elderly patients receiving primary care in Spain. Rev Esp Cardiol. 2005;58:359-66.
18. Banegas JR, Segura J, Ruilope LM, Luque M, García-Robles R, Campo C, et al; CLUE Study Group Investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension. 2004;43:1338-44.
19. Banegas JR, Ruilope LM, Vegazo O, Fernández R, De Rivas B, Ovejero C. Control of cardiovascular risk factors among hypertensives attended at hypertension units in Spain. The Coriva Study. J Hypertens. 2005;23 Suppl 2:181.
20. Álvarez-Sala LA, Suárez C, Mantilla T, Franch J, Ruilope LM, Banegas JR, et al; Grupo PREVENCAT. Estudio PREVENCAT: control del riesgo cardiovascular en atención primaria. Med Clin (Barc). 2005;124:406-10.
21. Coca A, Dalfó A, Esmatjes E, Llisterri JL, Ordóñez J, Gomis R, et al. Tratamiento y control del riesgo cardiovascular en atención primaria en España. Estudio PREVENCAT. Med Clin (Barc). 2006;126:201-5.
22. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356-62.
23. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-10.
24. Cuspidi C, Meani S, Salerno M, Severgnini B, Fusi V, Valerio C, et al. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria. Blood Press. 2004;13:144-51.
25. De Leeuw PW. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension. J Hypertens Suppl. 2001;19:S41-S5.
26. Ruzicka M, Leenen FH. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension. Drugs. 2001; 61:943-54.
27. Amar J, Vaur L, Perret M, Bailleau C, Etienne S, Chamontin B. Arterial hypertension management in general practice in France according to global risk factors. Arch Mal Coeur Vaiss. 2001; 94:843-5.
28. González-Santos P. Prevención cardiovascular en atención primaria. Med Clin (Barc). 2006;126:214-6.